# A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831

> **NCT04407091** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 8 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** 14C]AZD4831 Oral Solution

## Key facts

- **NCT ID:** NCT04407091
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-30
- **Primary completion:** 2020-08-06
- **Final completion:** 2020-08-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04407091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04407091, "A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04407091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*